We are live on ! Find out more
DDC

Daniel Devine & Co Portfolio holdings

AUM $125M
1-Year Est. Return 14.12%
This Fund
S&P 500
This Quarter Est. Return
+6.12%
1 Year Est. Return
+14.12%
3 Year Est. Return
+34.19%
5 Year Est. Return
10 Year Est. Return
AUM
$138M
AUM Growth
+$7.4M
Cap. Flow
-$504K
Cap. Flow %
-0.36%
Top 10 Hldgs %
69.63%
Holding
50
New
1
Increased
1
Reduced
20
Closed
2

Top Buys

Rank Stock Value
1
TGT icon
Target
TGT
+$662K

Sector Composition

Rank Sector Weight
1 Healthcare 12.46%
2 Financials 6.95%
3 Technology 6.71%
4 Energy 3.05%
5 Consumer Staples 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$32.4M 23.46%
121,537
-440
-0.4% -$114K
QQQ icon
2
Invesco QQQ Trust
QQQ
$453B
$18M 13.03%
115,630
MDY icon
3
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$16.1M 11.65%
46,615
AAPL icon
4
Apple
AAPL
$4.54T
$8.19M 5.92%
193,592
-660
-0.3% -$27.6K
JNJ icon
5
Johnson & Johnson
JNJ
$618B
$4.97M 3.59%
35,557
-850
-2% -$118K
IBB icon
6
iShares Biotechnology ETF
IBB
$9.34B
$4.55M 3.29%
42,585
EEM icon
7
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$3.23M 2.34%
68,600
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.11M 2.25%
15,700
ABBV icon
9
AbbVie
ABBV
$443B
$2.96M 2.14%
30,580
CVX icon
10
Chevron
CVX
$392B
$2.7M 1.95%
21,574
-294
-1% -$34.9K
V icon
11
Visa
V
$684B
$2.31M 1.67%
20,280
-200
-1% -$22.1K
PFE icon
12
Pfizer
PFE
$143B
$2.16M 1.56%
62,884
-685
-1% -$23.4K
FDX icon
13
FedEx
FDX
$72.7B
$2.12M 1.54%
8,510
-150
-2% -$34.3K
UNH icon
14
UnitedHealth
UNH
$376B
$1.98M 1.43%
8,965
-150
-2% -$31.8K
COST icon
15
Costco
COST
$422B
$1.87M 1.36%
10,065
NVS icon
16
Novartis
NVS
$297B
$1.82M 1.32%
24,161
ZTS icon
17
Zoetis
ZTS
$32.4B
$1.74M 1.26%
24,190
BLK icon
18
Blackrock
BLK
$169B
$1.73M 1.25%
3,360
-100
-3% -$48.6K
SBUX icon
19
Starbucks
SBUX
$120B
$1.7M 1.23%
29,615
DIS icon
20
Walt Disney
DIS
$167B
$1.63M 1.18%
15,152
-150
-1% -$15.5K
GOOG icon
21
Alphabet (Google) Class C
GOOG
$4.36T
$1.55M 1.12%
29,380
RDS.B
22
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$1.52M 1.1%
22,225
AZN icon
23
AstraZeneca
AZN
$263B
$1.3M 0.94%
18,700
TGT icon
24
Target
TGT
$65.6B
$1.3M 0.94%
19,860
+10,960
+123% +$662K
HBI
25
DELISTED
Hanesbrands
HBI
$1.27M 0.92%
60,695

Similar funds

Daniel Devine & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Daniel Devine & Co held 50 positions worth $138M, up 5.7% from $131M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Daniel Devine & Co's Q4 2017 filing shows 1 new, 1 increased, 20 reduced and 2 closed positions. The largest sale was GE Aerospace, an estimated $1.85M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 12% a quarter earlier, followed by Financials and Technology.

  • Daniel Devine & Co added most to Target in Q4 2017, an estimated $662K increase.
  • Daniel Devine & Co's biggest Q4 2017 reduction was State Street Industrial Select Sector SPDR ETF, cutting an estimated $155K.
  • Daniel Devine & Co fully exited GE Aerospace in Q4 2017, selling an estimated $1.85M.
  • Daniel Devine & Co's ten largest holdings make up 70% of its $138M portfolio in Q4 2017.
  • Daniel Devine & Co opened 1 new position and closed 2 in Q4 2017.
  • Daniel Devine & Co's portfolio value rose 5.7% quarter-over-quarter to $138M.

Based on Daniel Devine & Co's 13F filing for Q4 2017, filed 24 Jan 2018.